1982
Howard A. Rusk, M.D.’25
1983
Elizabeth K. Rose, M.D.’26
Edward Rose, M.D.’21
1984
Carl F. Schmidt, M.D.’18
1985
Michael S. Brown, M.D.’66
Seymour S. Kety, M.D.’40
1986
Stanley N. Cohen, M.D.’60
Eugene M. Landis, M.D.’26
1987
Louis Sokoloff, M.D.’46
Francis C. Wood, M.D.’26
1988
David E. Kuhl, M.D.’55
Truman G. Schnabel, Jr., M.D.’43D
1989
Christian J. Lambertsen, M.D.’43A
John T. Potts, M.D.’57
1990
Gerald M. Edelman, M.D.’54, Ph.D.
Frank A. Oski, M.D.’58
1991
Maria Iandolo New, M.D.’54
Stanley B. Pruisner, M.D.’68
1992
Leon Eisenberg, M.D. ’46
Peter C. Nowell, M.D.’52
1993
Jonathan E. Rhoads, M.D., GME’40
Harold M. Weintraub, M.D.’74, Ph.D.’71
1994
C. Everett Koop, M.D., GME’47
Darwin J. Prockop, M.D.’56, Ph.D.
1995
Robert E. Forster II, M.D.’43D
James E. Eckenhoff, M.D.’41
1996
Robert A. Fishman, M.D.’47
James D. Hardy, M.D.’42
1997
Jerome H. Grossman, M.D.’65
Juan M. Taveras, M.D.’49
1998
Albert M. Kligman, M.D.’47, Ph.D.’42
Clyde F. Barker, M.D., GME’59
1999
Herbert L. Needleman, M.D.’52
Matthew D. Davis, M.D.’50
2000
Joseph H. Burchenal, M.D.’37
Robert L. Barchi, M.D.’72, Ph.D.’72
2001
Daniel Albert, M.D.’62
Edward Holmes, M.D.’67
2002
John M. Eisenberg, M.D., M.B.A.’76, GME’77
Robert W. Miller, M.D.’46
James C. Thompson, M.D., GME’59
2003
H. Frank Bunn, M.D.’61
Robert B. Daroff, M.D.’61
2004
Selma E. Snyderman, M.D.’40
Edward J. Stemmler, M.D.’60
2005
Carl Brighton, M.D.’57
Jerome Strauss, M.D.’74 , Ph.D.’74
2006
Theodore Friedmann, M.D.’60
Helene Gayle, M.D.’81
John Christian Reed, M.D.’86, Ph.D.’86
2007
Stanley Dudrick, M’61, GME’67
Stanley Plotkin, GME’63
2008
Dennis A. Ausiello, M.D.‘71
Walter J. Gamble, M.D.‘57
Craig B. Thompson, M.D.‘77
2009
Mark T. Groudine, M.D.‘74, Ph.D.‘74
Nicole Lurie, M.D.‘79
2010
Ann Arvin, M.D.’72
Robert I. Grossman, M.D.’73
2011
Elaine S. Jaffe, M.D.’69
Sidney Pestka, M.D.’61
2012
David A. Asch, GM'87, WG'89, HOM'96
William S. Pierce, M'62, RES'69
2013
Richard H. Goodman, M.D.’76, Ph.D.’76
Jeannie T. Lee, M.D.’93, Ph.D.’93
2014
William A. Eaton, C’59, M’64, GR’67
Alan J. Wein, M’66, INT’70
2015
Patricia A. Gabow, M’69, INT’73
Robert M. Wachter, C’79, M’83
2016
William E. Bunney, M’56
Joseph Loscalzo, C’72, GR’76, M’78
2017
Peter J. Jannetta, C’53, M’57, INT’64
Frederick S. Kaplan, GM'81
2018
Richard Besser, M'86
Karl Rickels, FEL'57
2019
J. Sanford Schwartz, M’74, RES'77
Rajiv Shah, M’02, GRW’05
2020
Leonard Hayflick, C’51, G’53, GR’56
Gregg L. Semenza, M’82, GR’84
2021
Vanessa Northington Gamble, M'78, G'84, GR'87
Rita F. Redberg, M'81
2022
Alan R. Cohen, M'72, INT'76
James S. Forrester, M'63, RES'67
2023
Katrina A. Armstrong, MD, GM’98
Daniel R. Weinberger, M’73
2024
Lainie Friedman Ross, M'86, PhD
Ravi Ishwar Thadhani, M'91
Sankey V. Williams, MD, RES'77
Lainie Friedman Ross, M’86, PhD, a pediatrician and philosopher, is the Dean’s Professor and inaugural Chair of the Department of Health Humanities and Bioethics, the Director of the Paul M Schyve, MD Center for Bioethics, and holds secondary appointments in the Departments of Pediatrics and Philosophy at the University of Rochester School of Medicine and Dentistry. Prior to joining the University of Rochester in 2023, Dr. Ross spent 28 years at the University of Chicago where she was the Carolyn and Matthew Bucksbaum Professor of Clinical Ethics, Professor in the Departments of Pediatrics, Medicine, Surgery and The College, co-director of the Institute for Translational Medicine, and Associate Director of the MacLean Center for Clinical Medical Ethics.
Dr. Ross’ research portfolio addresses ethical and policy issues in organ and tissue transplantation, pediatrics, genetics, research ethics, and health care disparities. She and colleagues proposed the idea of kidney paired exchanges between incompatible donor-recipient pairs, which then evolved into kidney chains and now accounts for over 1,000 lives saved annually. She co-authored two seminal textbooks on deceased donor and living donor organ transplantation (with Robert M. Veatch, PhD, and J. Richard Thistlethwaite MD, PhD, respectively). In pediatrics, Dr. Ross challenged the “best interest of the child” standard as the appropriate guidance for intimate families. Her model of constrained parental autonomy, published by Oxford University Press, provides a moral approach to the triadic pediatric relationship (doctor, patient, and parents).
Most of Dr. Ross’ attention toward genetics has been focused on newborn screening policies; in research ethics, she has served on the Secretary’s Advisory Committee on Human Research Protections (SACHRP), the Recombinant DNA Advisory Committee (RAC), and numerous National Institutes of Health (NIH) Data Safety Monitoring committees. Dr. Ross’ work in disparities has explored and proposed solutions to the over-representation of women as living organ donors, the under-representation of women and Blacks as organ recipients, and the racial and ethnic disparities caused by different genetic screening methodologies and policies.
Dr. Ross is a graduate of the School of Public and International Affairs at Princeton University (AB), the Perelman School of Medicine at the University of Pennsylvania (MD), and Yale University (MPhil and PhD in Philosophy). She trained in pediatrics at the Children’s Hospital of Philadelphia and the Morgan Stanley Children's Hospital of New York-Presbyterian. She is a John Simon Guggenheim Memorial Foundation Fellow and a member of the National Academy of Medicine. She and her husband, John Ross, have two children.
Ravi Ishwar Thadhani, M’91, MPH, is the Executive Vice President for Health Affairs (EVPHA) of Emory University, Executive Director of Emory’s Woodruff Health Sciences Center (WHSC), and Vice Chair of the Emory Healthcare Board of Directors. The Woodruff Health Sciences Center includes Emory’s schools of medicine, public health and nursing; Winship Cancer Institute; Emory National Primate Research Center; Emory Global Health Institute; Goizueta Institute @ Emory Brain Health; Emory Global Diabetes Research Center; and Emory Healthcare. Emory Healthcare, with more than 24,000 employees, 11 hospital campuses and 425 locations, is the most comprehensive academic health system in Georgia.
Dr. Thadhani oversees Emory’s renowned academic health sciences enterprise, focused on advancing research, training, and health-care delivery innovation. As vice chair of the Emory Healthcare board, he provides guidance for Emory Healthcare’s CEO and leadership team, ensuring the delivery of high-quality, patient-centered care focused on supporting the health and well-being of patients around the state.
Dr. Thadhani most recently served as chief academic officer and dean for faculty affairs for Mass General Brigham and professor of medicine at Harvard Medical School, both in Boston, Massachusetts. As a member of the executive leadership team, he oversaw graduate medical education, professional development, and a $2.3 billion research enterprise. Previously, Dr. Thadhani served as vice dean of research and graduate research education at Cedars-Sinai Medical Center in Los Angeles (2017- 2019), associate director of research at Mass General Brigham (2012-2017), and chief of nephrology at Massachusetts General Hospital (2013-2017).
With more than 30 years as a general and specialized internal medicine physician, Dr. Thadhani has extensive experience in patient care, research, and clinical trials. He led a successful research lab with continuous federal funding for more than 25 years, with a focus on kidney disease and developing diagnostics and therapeutics for patients with preeclampsia. He and his colleagues developed the first FDA approved test for preeclampsia (May 2023), and he is now working on a therapy for this devastating condition. He is the author or co-author of more than 300 scientific manuscripts and has published in top-tier journals, including
The New England Journal of Medicine, Lancet, and Journal of the American Medical Association.
A recipient of several distinguished national awards, Dr. Thadhani has been inducted into a number of honor societies, including the American Society for Clinical Investigation, Association of American Physicians, American Epidemiological Society, and the American Clinical and Climatological Association. He has an extensive track record of recruiting and mentoring women and underrepresented staff, trainees, and faculty, and has been honored with the Harold Amos Faculty Diversity Award from Harvard Medical School, the Alumni Award of Merit from the Harvard T.H. Chan School of Public Health, and the John P. Peters Award from the American Society of Nephrology.
Dr. Thadhani received a bachelor’s degree from the University of Notre Dame. He earned his Doctor of Medicine degree from the Perelman School of Medicine at the University of Pennsylvania in 1991. At Penn, he was awarded the Nathan and Paulin Pincus Prize for Outstanding Achievement as a Clinician and the Alfred Stengel MD Memorial Prize for Academic Excellence in Academic Medicine, and he was inducted into Alpha Omega Alpha in 1990. Dr. Thadhani earned a Master of Public Health degree from the Harvard T.H. Chan School of Public Health, and he also completed the LEAD Innovation Certificate Program in 2020 at the Stanford University Graduate School of Business.
2018 Recipients
Richard Besser, M'86
Richard Besser, M'86, is president and CEO of the Robert Wood Johnson Foundation. He is the former acting director for the Centers for Disease Control and Prevention (CDC), and ABC News’ former Chief Health and Medical Editor.
At RWJF, Dr. Besser leads the largest private foundation in the country devoted solely to improving the nation’s health. In his role at ABC News, Dr. Besser provided medical analysis and reports for all ABC News programs and platforms. His weekly health chats on social media reached millions.
Before joining ABC News in 2009, Dr. Besser worked as Director of the Coordinating Office for Terrorism Preparedness and Emergency Response at the CDC. In that role, he was responsible for all the CDC's public health emergency preparedness and emergency response activities. He also served as acting director of the CDC from January to June 2009, during which time he led the CDC's response to the H1N1 influenza pandemic.
Dr. Besser’s tenure at the CDC began in 1991 working on the epidemiology of food-borne illness. He then served for five years on the faculty of the University of California, San Diego as the pediatric residency director, while also conducting research and working for the county health department on the control of pediatric tuberculosis. He returned to the CDC in 1998 as an infectious disease epidemiologist working on pneumonia, antibiotic resistance and the control of antibiotic overuse.
Dr. Besser received his Bachelor of Arts degree in economics from Williams College and his medical degree from the University of Pennsylvania. He completed a residency in pediatrics at Johns Hopkins University Hospital in Baltimore where he was chief resident. He volunteered for seven years as a pediatrician with the Children's Aid Society in New York City, and he is currently a Professor of Pediatrics at Columbia University and a Distinguished Visiting Fellow at the Harvard School of Public Health.
Karl Rickels, FEL'57
Karl Rickels, FEL'57, is the Stuart and Emily Mudd Professor of Human Behavior and Professor of Psychiatry at the Perelman School of Medicine. He is a Distinguished Life Fellow of the American Psychiatric Association and Charter and Life Fellow of the American College of Neuropsychopharmacology, who received his medical training in Germany and completed his psychiatric training at the Hospital of the University of Pennsylvania in 1957.
Dr. Rickels is an internationally recognized expert in psychopharmacology, with particular interest in anxiety disorders. He has written or edited 10 books and authored or co-authored more than 600 peer-reviewed publications, book chapters, and reviews. Since 1959, Dr. Rickels’ research has received continuous support from NIMH—including a prestigious Merit Award in 1988, starting with grant MH02914 in 1959 and ending with grant MH65963 in 2009. His main area of academic interest is the psychopathology and treatment of anxiety disorders, depression and premenstrual syndrome, benzodiazepine dependence, and research methodology.
Nationally, Dr. Rickels has served on peer review panels at the NIMH, and on advisory committees to the FDA—including chairing the FDA Over-the Counter Review Committee on over-the-counter daytime and nighttime sedatives and stimulants from 1972-1975.
At Penn, Dr. Rickels served on the Committee on Appointments and Promotion from 1977-1984, chaired the University Institutional Review Board from 1982-1998, and chaired the Department of Psychiatry COAP from 2003-2017.
Over the past 25 years, Dr. Rickels has established 3 endowed chairs at Penn: the Karl E. Rickels Professorship in 1993; the Karl and Linda Rickels Professorship in 1999; and the Roehrhoff Rickels Professorship in 2015.
2017 Recipients
Peter J. Jannetta, C’53, M’57, INT’64
The late Peter J. Jannetta, C’53, M’57, INT’64, was an internationally recognized neurosurgeon and the long-time chair of neurosurgery at the University of Pittsburgh. Dr. Jannetta will receive the award posthumously, after his death at 84 in April 2016. Dr. Jannetta developed an innovative neurological technique, known as the Jannetta procedure, which is now the gold standard for relieving facial spasms and excruciating pain caused by trigeminal neuralgia. The microsurgical technique involves identifying and relieving pressure from the blood vessel compressing the trigeminal nerve. While unprecedented and somewhat controversial when Dr. Jannetta first developed it as a neurosurgical resident at UCLA, the technique now has a recognized 90% success rate for alleviating pain, and has impacted the lives of thousands of patients.
Dr. Jannetta’s exceptional contributions to the field of medicine and his standing as a noble physician qualified him for this recognition. Upon learning that he was to receive the DGA, a point of pride for him to be recognized by his beloved Penn, he started writing his remarks. His daughter, Joanne J. Lenert, M’85, will proudly deliver Dr. Jannetta’s message and accept the award on behalf of the family. She will be joined by her mother, Diana, her daughter, Susan and many members of the family for what would have been Dr. Jannetta’s 60th Reunion.
Frederick S. Kaplan, GM'81
Frederick S. Kaplan, GM’81, is the Isaac and Rose Nassau Professor of Orthopaedic Molecular Medicine and Chief of the Division of Molecular Orthopaedic Medicine at the Perelman School of Medicine. He is an alumnus of the Johns Hopkins University School of Medicine and the University of Pennsylvania Orthopaedics Residency Program.
In 1989, Dr. Kaplan, as an orthopaedic surgeon, met a child with fibrodysplasia ossificans progressiva (FOP), a rare and disabling condition in which the body forms a second skeleton of heterotopic bone. Motivated to know and do more, Dr. Kaplan began a pioneering second career in FOP research: work that led to the discovery of the FOP gene, the fundamental target for all therapeutic efforts for this condition.
Dr. Kaplan, along with his colleague Dr. Eileen M. Shore, PhD, the Cali-Weldon Research Professor of FOP, co-directs the Penn Center for Research in FOP and Related Disorders—the only center in the world devoted entirely to this work—and has organized the medical and scientific communities worldwide on this rare condition. He is recognized as the world’s leading expert on FOP. In 1997, he was awarded the first endowed chair for orthopaedic molecular medicine in the nation. In 2009, Dr. Kaplan was elected to the Institute of Medicine.
The late Victor McKusick, considered the father of clinical genetics, described Dr. Kaplan as “one of the really outstanding orthopaedic researchers of his generation. His work with FOP has been extraordinary and extends all the way from the patients to the bench and back again. The devotion of the families and the patients to him is testimony to the kind of human being he is.” Dr. Kaplan was cited in 2006 in Newsweek as one of the 15 people who make America great: “the disease was so rare, nobody wanted to deal with it until he came along.”
2016 Recipients
William E. Bunney, M'56
William E. Bunney, M’56, is a national and international award-winning researcher. His work has provided invaluable evidence
regarding the causes and treatment for major psychiatric disorders, including major depressive disorder, bipolar disorder, and schizophrenia.
Dr. Bunney received his MD from the Perelman School of Medicine and completed his residency in psychiatry at Yale University School of Medicine.
Following his residency, he was recruited by Dr. David Hamburg to the Intramural Program of the National Institutes of Mental Health (NIMH),
where he later held several leadership positions, including three years as Director of the Division of Narcotic Addiction and Drug Abuse. During
his tenure, his division expanded the number of drug addiction treatment centers six-fold throughout the nation, and established eight
university-based research programs on substance abuse.
Currently at the School of Medicine, University of California Irvine, Dr. Bunney is a Distinguished Professor and the Associate Dean for Research
Administration and Development. He continues to be actively involved in research, and has had 17 publications in major journals over the last
three years. He is the senior author on a notable paper presenting the first direct evidence for clock gene abnormalities in major depressive
disorder, which has been ranked in the top 98% of all downloaded papers published by the Proceedings of the National Academy of
Sciences.
Dr. Bunney was elected to the National Academy of Medicine of the National Academy of Sciences—subsequently designated a Lifetime National
Associate of the National Academies—and was appointed for a term as Executive Vice President of the National Academies Corporation. He is the
author of over 447 scientific publications, and his papers have been cited more than 34,000 times.
Dr. Bunney has received many national and international research awards, including the APA Hofheimer Research Award, the International Anna-
Monika Award and the NARSAD Nora Maddox Falcone Prize for Outstanding Achievement in Affective Disorders Research. He was awarded the 2011 Rhoda
and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine/National Academy of Sciences, the 2012 Pioneer
Award from the Collegium Internationale Neuro-psychopharmacologicum (CINP), the 2012 Yale Psychiatry Distinguished Alumni Award and, in 2015, the
Payne Whitney Clinic Award for Extraordinary Public Service from the Department of Psychiatry, Weill Medical College at Cornell University.
Joseph Loscalzo, C’72, GR’76, M’78
Joseph Loscalzo, C’72, GR’76, M’78 is a cardiovascular medicine specialist nationally renowned for his work in vascular biology, thrombosis, atherosclerosis, and systems biology. His most recent work has established the field of network medicine, a paradigm-changing discipline using systems biology and network science to redefine disease and therapeutics from an integrated perspective. Dr. Loscalzo has also authored or co-authored more than 800 scientific publications, authored or edited 40 books, and holds 31 patents for his work in the field of nitric oxide and redox biology.
Currently, Dr. Loscalzo is the Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School, Chair of the Department of Medicine, and Physician-in-Chief at Brigham and Women’s Hospital. He received his AB degree, summa cum laude, his PhD in biochemistry, and his MD from the University of Pennsylvania. His clinical training was completed at Brigham and Women’s Hospital and Harvard Medical School, where he served as Resident and Chief Resident in medicine and Fellow in cardiovascular medicine.
Dr. Loscalzo has served on several National Institutes of Health (NIH) study sections and editorial boards, and chaired the international Gordon Conference on Thrombolysis. He served as an associate editor of the New England Journal of Medicine for nine years, Chair of the Cardiovascular Board of the American Board of Internal Medicine, Chair of the Research Committee of the American Heart Association, and Chair of the Board of Scientific Counselors of the National Heart, Lung, and Blood Institute. He is currently Director of the NIH-funded Center for Accelerated Innovation (the Boston Biomedical Innovation Center), the NIH-funded Harvard Undiagnosed Disease Network program, the recipient of an NIH MERIT Award, Editor-in-Chief of Circulation, and a senior editor of Harrison’s Principles of Internal Medicine.
Dr. Loscalzo is the recipient of numerous awards and honors, including the George W. Thorn Award for Excellence in Teaching at Brigham and Women’s Hospital, the Educator of the Year Award in Clinical Medicine from Boston University, the William Silen Lifetime Achievement in Mentorship Award from Harvard Medical School, as well as the Distinguished Scientist Award, the Research Achievement Award, and the Paul Dudley White Award from the American Heart Association. He is an elected member of the National Academy of Medicine and the American Academy of Arts and Sciences.
2015 Recipients
Patricia Acquaviva Gabow, M’69, INT’73
Patricia Acquaviva Gabow, M’69, INT’73, is nationally renowned for her work to increase access to basic health care in Colorado, and has led a successful career as a researcher, physician, and health care leader. She is the recipient of numerous awards, and has been named as one of the top 25 women in health care, one of the top 50 physician executives, and one of the 100 most powerful people in American health care.
As CEO of Denver Health and Hospitals—from 1992 until her retirement in 2012—Dr. Gabow transformed its health care system into a national model for its superior quality of care. Because of her efforts, Denver Health earned the Shingo Bronze Medallion for Operational Excellence: the first health care entity to receive such recognition. Most recently, Dr. Gabow she has been appointed to MACPAC, the federal commission on Medicaid and CHIP, and is Senior Advisor to Simpler Consulting. She is also a member of the Robert Wood Johnson Foundation Board of Trustees, the Institute of Medicine’s Roundtable on Value and Science Driven Health Care, and the National Governors’ Association Health Advisory Board.
Dr. Gabow is Professor of Medicine at the University of Colorado School of Medicine, and has authored more than 150 publications, including articles, book chapters, and books. Her most recent book is The Lean Prescription: Powerful Medicine for Our Ailing Healthcare System. A loyal and active Perelman School alumna, she was chosen as the keynote speaker at Penn Medicine’s Women in Medicine event in 2009.
Dr. Gabow attended Seton Hill College as an undergraduate, received her medical degree from the Perelman School of Medicine, and completed an internship in Medicine as well as a nephrology fellowship at the Hospital of the University of Pennsylvania.
Robert M. Wachter, C’79, M’83
Robert M. Wachter, C’79, M’83, is considered the father of the hospitalist field. Originally coining the term in a New England Journal of Medicine article in 1996, he has become a national leader of the fastest-growing specialty in the history of modern medicine. He is also a well-respected expert in the fields of patient safety and healthcare quality.
In 2004, Dr. Wachter received the John M. Eisenberg Award, the nation’s top honor in patient safety. He has been named one of Modern Healthcare magazine’s 50 most influential physician-executives in the US for the past seven years—the only academic physician to receive this recognition. In 2014, the same publication listed him as one of the 100 most influential people in healthcare.
In the patient safety and quality arenas, Dr. Wachter edits the AHRQ WebM&M, a case-based patient safety journal on the Web, and AHRQ Patient Safety Network, the leading federal patient safety portal. He has written two books on these subjects, including Internal Bleeding—an Amazon best seller—and Understanding Patient Safety, the leading safety primer. His newest book, The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine’s Computer Age, was published in April 2015. Dr. Wachter’s blog, www.wachtersworld.org, is one of the nation’s most popular healthcare blogs.
Dr. Wachter is currently Professor and Associate Chairman of the Department of Medicine at the University of California, San Francisco, where he holds the Lynne and Marc Benioff Endowed Chair in Hospital Medicine. He is also Chief of the Division of Hospital Medicine and Chief of the Medical Service at UCSF Medical Center.
Dr. Wachter received his undergraduate degree at the University of Pennsylvania and his medical degree from the Perelman School of Medicine, and completed a residency and chief residency in internal medicine at University of California, San Francisco. He was a Robert Wood Johnson Clinical Scholar at Stanford University, and studied patient safety in England in 2011 as a Fulbright Scholar.
2014 Recipients
William A. Eaton, C’59, M’64, GR’67
William A. Eaton, C’59, M’64, GR’67, is internationally recognized for his pioneering research on the physical chemistry of proteins. He is NIH Distinguished Investigator in the National Institute of Diabetes and Digestive and Kidney Diseases at NIH in Bethesda, Maryland, which he joined in 1968 as a medical officer in the US Public Health Service.
Dr. Eaton also earned his doctorate in molecular biology from Penn. His investigations of the kinetics and thermodynamics of the aggregation of sickle cell hemoglobin exemplify the role of biophysical studies in providing major breakthroughs in understanding a human disease. He discovered and explained the highly unusual time course and sensitivity of sickle hemoglobin fiber formation and showed how they play a central role in both the pathophysiology and therapy of sickle cell disease.
Dr. Eaton has made significant contributions to the field of protein folding by pioneering the application of pulsed lasers to dramatically improve the time resolution in kinetic studies and by developing single molecule fluorescence methods to watch individual molecules fold and unfold. This work has led to major advances in understanding how the random conformations of the polypeptide chain self-assemble into the biologically active folded structure. All of Dr. Eaton’s experiments have been closely tied to theory, culminating in his development of a mathematical model of protein folding capable of quantitatively explaining a wide range of equilibrium and kinetic experimental results.
Dr. Eaton has also played a major leadership role at NIH. As Chief of the Laboratory of Chemical Physics since 1986, he has been responsible for building what is arguably one of the very top groups of biophysical scientists anywhere. As Scientific Director of the Intramural AIDS Targeted Anti-viral Program (IATAP) in the Office of the Director of NIH since 1986, his program has attracted many of NIH’s very best scientists to turn their efforts to research on the structural, molecular, and cell biology of HIV/AIDS. The IATAP program has contributed to the strong record of NIH scientists in meeting the AIDS crisis, and is now being used as a model for new granting programs within NIH in areas such as bioterrorism and orphan diseases research.
Dr. Eaton is a member of the American Academy of Arts and Sciences and the National Academy of Sciences. His awards include the Neurath Award of the Protein Society, the Founders Award of the Biophysical Society, the Delbruck Prize in Biological Physics from the American Physical Society, and the John Scott Award of the City of Philadelphia.
Alan J. Wein, M’66, INT’70
Alan J. Wein, M’66, INT’70, has dedicated his life to the field of urology and his career to Penn Medicine. In 2012, Dr. Wein was a recipient of The Edward L. Keyes Medal, presented by the American Association of Genitourinary Surgeons for “outstanding contributions in the advancement of urology.” The Keyes Medal is recognized as the greatest individual citation in urology and has been awarded rarely since its inception in 1926.
At Penn, Dr. Wein has held positions along the entire professional spectrum as student, to researcher, to clinician, and now as Professor and Chief of the Division of Urology at the University of Pennsylvania, and Chief of Urology and Director of the Residency Program in Urology for Penn Medicine.M
Through Dr. Wein’s leadership, the Division is now considered among the nation’s leading centers for excellence in urology and urologic surgery. Under his direction, the Residency Program in Urology ranks among the top 5 in the country. In 2007, Dr. Wein was named the Founders Professor in Urology, which was created in recognition of his leadership and accomplishments.
Among his many honors, Dr. Wein is a recipient of the Urodynamics Society Lifetime Achievement Award, both the Distinguished Service and the Distinguished Contribution Awards of the American Urological Association, and the Ferdinand C. Valentine Award of the New York Academy of Medicine.
Dr. Wein holds or has held editorial board or associate editor positions on 15 respected journals, authored or coauthored over 925 scientific publications or chapters and over 785 editorials, and written, edited, or coedited over 30 books on urologic topics. He is editor-in-chief of the gold standard textbook in urology, Campbell-Walsh Urology.
His laboratory is well recognized for numerous contributions to the physiology and pharmacology of the lower urinary tract, and Dr. Wein is widely acknowledged for his simplified and now commonly used approach for classification, evaluation, and management of lower urinary tract dysfunction, including incontinence, the effects of neuromuscular disease, and obstruction. He is also recognized for his primary role in developing the concept and terminology for the overactive bladder symptom syndrome and its diagnosis and noninvasive therapy. A founding member of the Society of Urologic Oncology, he directs the Urologic Cancer Program at Penn.
After graduating from Princeton University, Dr. Wein received his MD and completed training in surgery and urology at Penn, including a fellowship at the Harrison Department of Surgical Research. He was awarded an honorary PhD from the University of Patras, Greece, in 2005. He was conferred the status of Honorary Professor of the Federal State Institute of Urology by the Russian Ministry of Healthcare and Social Development in 2010.